In addition to receiving financial assistance under Mission Covid Suraksha, this vaccine candidate has also obtained financial support under Covid-19 Research Consortia through the BIRAC's National Biopharma Mission.
The trial will be on children between 5 and 18 years of age with certain conditions and conducted in 10 locations across the country,
It pointed out that the proposal of the company concerned was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).
